Immunohistochemical localization of somatostatin receptor subtypes in benign and malignant adrenal tumours

Clinical Endocrinology

Volumn 68, Issue 6, 2008, Pages 850-857

  Unger, Nicole ^a   Serdiuk, Inna ^a   Sheu, Sien Yi ^b   Walz, Martin K ^c   Schulz, Stefan ^d   Saeger, Wolfgang ^e   Schmid, Kurt W ^b   Mann, Klaus ^a   Petersenn, Stephan ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c KLINIKEN ESSEN MITTE   (Germany)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

^e Marien Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; HYDROCORTISONE; POLYCLONAL ANTIBODY; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR 3; SOMATOSTATIN RECEPTOR 4;

ADRENAL CORTEX; ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADRENAL TUMOR; ARTICLE; CONTROLLED STUDY; ENDOCRINE TUMOR; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; HYPOPHYSIS TUMOR; IMMUNOHISTOCHEMISTRY; NEUROENDOCRINE TUMOR; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 43949088527     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.03124.x     Document Type: Article

References (49)

1. 1 Brazeau, P. Jr, Saucier, R. & Husain, S.M. (1972) Activity of somatotropin releasing hormone, hypophyseal somatotropin, and plasma growth hormone‐like activity in adult and immature female rats treated with Enovid [in French]. Canadian Journal of Physiology and Pharmacology, 50, 967–970.
2. 2 Patel, Y.C. (1999) Somatostatin and its receptor family. Frontiers in Neuroendocrinology, 20, 157–198.
3. 3 Aguila, M.C., Rodriguez, A.M., Aguila‐Mansilla, H.N. & Lee, W.T. (1996) Somatostatin antisense oligodeoxynucleotide‐mediated stimulation of lymphocyte proliferation in culture. Endocrinology, 137, 1585–1590.
4. 4 Karalis, K., Mastorakos, G., Chrousos, G.P. & Tolis, G. (1994) Somatostatin analogues suppress the inflammatory reaction in vivo. Journal of Clinical Investigation, 93, 2000–2006.
5. 5 Reisine, T. & Bell, G.I. (1995) Molecular biology of somatostatin receptors. Endocrine Reviews, 16, 427–442.
6. 6 Sharma, K., Patel, Y.C. & Srikant, C.B. (1996) Subtype‐selective induction of wild‐type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3. Molecular Endocrinology, 10, 1688–1696.
7. 7 Sharma, K., Patel, Y.C. & Srikant, C.B. (1999) C‐terminal region of human somatostatin receptor 5 is required for induction of Rb and G1 cell cycle arrest. Molecular Endocrinology, 13, 82–90.
8. 8 Bruns, C., Raulf, F., Hoyer, D., Schloos, J., Lubbert, H. & Weckbecker, G. (1996) Binding properties of somatostatin receptor subtypes. Metabolism, 45, 17–20.
9. 9 Freda, P.U. (2002) Somatostatin analogs in acromegaly. Journal of Clinical Endocrinology and Metabolism, 87, 3013–3018.
10. 10 Oberg, K., Kvols, L., Caplin, M., Delle Fave, G., De Herder, W., Rindi, G., Ruszniewski, P., Woltering, E.A. & Wiedenmann, B. (2004) Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system. Annals of Oncology, 15, 966–973.
11. 11 Bruns, C., Lewis, I., Briner, U., Meno‐Tetang, G. & Weckbecker, G. (2002) SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile. European Journal of Endocrinology, 146, 707–716.
12. 12 Mundschenk, J., Unger, N., Schulz, S., Hollt, V., Schulz, S., Steinke, R. & Lehnert, H. (2003) Somatostatin receptor subtypes in human pheochromocytoma: subcellular expression pattern and functional relevance for octreotide scintigraphy. Journal of Clinical Endocrinology and Metabolism, 88, 5150–5157.
13. 13 Ueberberg, B., Tourne, H., Redman, A., Walz, M.K., Schmid, K.W., Mann, K. & Petersenn, S. (2005) Differential expression of the human somatostatin receptor subtypes sst1 to sst5 in various adrenal tumors and normal adrenal gland. Hormone and Metabolic Research, 37, 722–728.
14. 14 Mundschenk, J. & Lehnert, H. (1998) Malignant pheochromocytoma. Experimental and Clinical Endocrinology and Diabetes, 106, 373–376.
15. 15 Unger, N., Lopez Schmidt, I., Pitt, C., Walz, M.K., Philipp, T., Mann, K. & Petersenn, S. (2004) Comparison of active renin concentration and plasma renin activity for the diagnosis of primary hyperaldosteronism in patients with an adrenal mass. European Journal of Endocrinology, 150, 517–523.
16. 16 Kumar, U., Sasi, R., Suresh, S., Patel, A., Thangaraju, M., Metrakos, P., Patel, S.C. & Patel, Y.C. (1999) Subtype‐selective expression of the five somatostatin receptors (hSSTR1–5) in human pancreatic islet cells: a quantitative double‐label immunohistochemical analysis. Diabetes, 48, 77–85.
17. 17 Le Romancer, M., Cherifi, Y., Levasseur, S., Laigneau, J.P., Peranzi, G., Jais, P., Lewin, M.J. & Reyl‐Desmars, F. (1996) Messenger RNA expression of somatostatin receptor subtypes in human and rat gastric mucosae. Life Sciences, 58, 1091–1098.
18. 18 Pfeiffer, M., Koch, T., Schroder, H., Klutzny, M., Kirscht, S., Kreienkamp, H.J., Hollt, V. & Schulz, S. (2001) Homo‐ and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A). Journal of Biological Chemistry, 276, 14027–14036.
19. 19 Pfeiffer, M., Koch, T., Schroder, H., Laugsch, M., Hollt, V. & Schulz, S. (2002) Heterodimerization of somatostatin and opioid receptors cross‐modulates phosphorylation, internalization, and desensitization. Journal of Biological Chemistry, 277, 19762–19772.
20. 20 Schulz, S., Pauli, S.U., Schulz, S., Handel, M., Dietzmann, K., Firsching, R. & Hollt, V. (2000) Immunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype sst2A. Clinical Cancer Research, 6, 1865–1874.
21. 21 Schulz, S., Schmidt, H., Handel, M., Schreff, M. & Hollt, V. (1998) Differential distribution of alternatively spliced somatostatin receptor 2 isoforms (sst2A and sst2B) in rat spinal cord. Neuroscience Letters, 257, 37–40.
22. 22 Schulz, S., Schulz, S., Schmitt, J., Wiborny, D., Schmidt, H., Olbricht, S., Weise, W., Roessner, A., Gramsch, C. & Hollt, V. (1998) Immunocytochemical detection of somatostatin receptors sst1, sst2A, sst2B, and sst3 in paraffin‐embedded breast cancer tissue using subtype‐specific antibodies. Clinical Cancer Research, 4, 2047–2052.
23. 23 Kulaksiz, H., Eissele, R., Rossler, D., Schulz, S., Hollt, V., Cetin, Y. & Arnold, R. (2002) Identification of somatostatin receptor subtypes 1, 2A, 3, and 5 in neuroendocrine tumours with subtype specific antibodies. Gut, 50, 52–60.
24. 24 Schulz, S., Helmholz, T., Schmitt, J., Franke, K., Otto, H.J. & Weise, W. (2002) True positive somatostatin receptor scintigraphy in primary breast cancer correlates with expression of sst2A and sst5. Breast Cancer Research and Treatment, 72, 221–226.
25. 25 Schulz, S., Schmitt, J., Quednow, C., Roessner, A. & Weise, W. (2002) Immunohistochemical detection of somatostatin receptors in human ovarian tumors. Gynecologic Oncology, 84, 235–240.
26. 26 Pisarek, H. & Pawlikowski, M. (2002) Immunohistochemical localization of the somatostatin receptor subtype 2A in the rat adrenal gland. Folia Histochemistry and Cytobiology, 40, 27–30.
27. 27 Epelbaum, J., Bertherat, J., Prevost, G., Kordon, C., Meyerhof, W., Wulfsen, I., Richter, D. & Plouin, P.F. (1995) Molecular and pharmacological characterization of somatostatin receptor subtypes in adrenal, extraadrenal, and malignant pheochromocytomas. Journal of Clinical Endocrinology and Metabolism, 80, 1837–1844.
28. 28 Kubota, A., Yamada, Y., Kagimoto, S., Shimatsu, A., Imamura, M., Tsuda, K., Imura, H., Seino, S. & Seino, Y. (1994) Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201–995 in treatment of human endocrine tumors. Journal of Clinical Investigation, 93, 1321–1325.
29. 29 O’Carroll, A.M. (2003) Localization of messenger ribonucleic acids for somatostatin receptor subtypes (sstr1–5) in the rat adrenal gland. Journal of Histochemistry and Cytochemistry, 51, 55–60.
30. 30 Reubi, J.C., Waser, B., Schaer, J.C. & Laissue, J.A. (2001) Somatostatin receptor sst1–sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype‐selective ligands. European Journal of Nuclear Medicine, 28, 836–846.
31. 31 Maurer, R. & Reubi, J.C. (1986) Somatostatin receptors in the adrenal. Molecular and Cellular Endocrinology, 45, 81–90.
32. 32 Morel, G., Leroux, P., Garcia Caballero, T., Beiras, A. & Gossard, F. (1990) Ultrastructural distribution of somatostatin‐14 and ‐28 in rat adrenal cells. Cell and Tissue Research, 261, 517–524.
33. 33 Aguilera, G., Harwood, J.P. & Catt, K.J. (1981) Somatostatin modulates effects of angiotensin II in adrenal glomerulosa zone. Nature, 292, 262–263.
34. 34 Role, L.W., Leeman, S.E. & Perlman, R.L. (1981) Somatostatin and substance P inhibit catecholamine secretion from isolated cells of guinea‐pig adrenal medulla. Neuroscience, 6, 1813–1821.
35. 35 Boscaro, M., Scaroni, C., Edwards, C.R. & Mantero, F. (1982) Inhibitory effect of somatostatin on the aldosterone response to angiotensin II: in vitro studies. Journal of Endocrinological Investigation, 5, 173–177.
36. 36 Jones, C.R., Millar, J.A., Lawrie, C., Sumner, D.J. & Reid, J.L. (1984) Specific inhibition of aldosterone responses to endogenous and exogenous angiotensin II by somatostatin. Clinical Endocrinology, 21, 279–284.
37. 37 Mazzocchi, G., Malendowicz, L.K., Meneghelli, V. & Nussdorfer, G.G. (1992) Evidence that endogenous somatostatin (SRIF) exerts a tonic inhibitory effect on the rat renin–angiotensin–aldosterone system. In Vivo, 6, 9–12.
38. 38 Rebuffat, P., Belloni, A.S., Musajo, F.G., Rocco, S., Markowska, A., Mazzocchi, G. & Nussdorfer, G.G. (1994) Evidence that endogenous somatostatin (SRIF) exerts an inhibitory control on the function and growth of rat adrenal zona glomerulosa. The possible involvement of zona medullaris as a source of endogenous SRIF. Journal of Steroid Biochemistry and Molecular Biology, 48, 353–360.
39. 39 Reubi, J.C., Maurer, R., Von Werder, K., Torhorst, J., Klijn, J.G. & Lamberts, S.W. (1987) Somatostatin receptors in human endocrine tumors. Cancer Research, 47, 551–558.
40. 40 Hofland, L.J., Liu, Q., Van Koetsveld, P.M., Zuijderwijk, J., Van Der Ham, F., De Krijger, R.R., Schonbrunn, A. & Lamberts, S.W. (1999) Immunohistochemical detection of somatostatin receptor subtypes sst1 and sst2A in human somatostatin receptor positive tumors. Journal of Clinical Endocrinology and Metabolism, 84, 775–780.
41. 41 Kimura, N., Pilichowska, M., Date, F., Kimura, I. & Schindler, M. (1999) Immunohistochemical expression of somatostatin type 2A receptor in neuroendocrine tumors. Clinical Cancer Research, 5, 3483–3487.
42. 42 Reubi, J.C., Kappeler, A., Waser, B., Laissue, J., Hipkin, R.W. & Schonbrunn, A. (1998) Immunohistochemical localization of somatostatin receptors sst2A in human tumors. American Journal of Pathology, 153, 233–245.
43. 43 Reubi, J.C., Waser, B., Liu, Q., Laissue, J.A. & Schonbrunn, A. (2000) Subcellular distribution of somatostatin sst2A receptors in human tumors of the nervous and neuroendocrine systems: membranous versus intracellular location. Journal of Clinical Endocrinology and Metabolism, 85, 3882–3891.
44. 44 Reubi, J.C., Waser, B., Khosla, S., Kvols, L., Goellner, J.R., Krenning, E. & Lamberts, S. (1992) In vitro and in vivo detection of somatostatin receptors in pheochromocytomas and paragangliomas. Journal of Clinical Endocrinology and Metabolism, 74, 1082–1089.
45. 45 Zatelli, M.C., Piccin, D., Bondanelli, M., Tagliati, F., De Carlo, E., Culler, M.D. & Uberti, E.C. (2003) An in vivo OctreoScan‐negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro. Hormone and Metabolic Research, 35, 349–354.
46. 46 Boksa, P., St‐Pierre, S. & Livett, B.G. (1982) Characterization of substance P and somatostatin receptors on adrenal chromaffin cells using structural analogues. Brain Research, 245, 275–283.
47. 47 Maurea, S., Lastoria, S., Caraco, C., Klain, M., Varrella, P., Acampa, W., Muto, P. & Salvatore, M. (1996) The role of radiolabeled somatostatin analogs in adrenal imaging. Nuclear Medicine and Biology, 23, 677–680.
48. 48 Van Der Harst, E., De Herder, W.W., Bruining, H.A., Bonjer, H.J., De Krijger, R.R., Lamberts, S.W., Van De Meiracker, A.H., Boomsma, F., Stijnen, T., Krenning, E.P., Bosman, F.T. & Kwekkeboom, D.J. (2001) [123,I]metaiodobenzylguanidine and [(111)In]octreotide uptake in benign and malignant pheochromocytomas. Journal of Clinical Endocrinology and Metabolism, 86, 685–693.
49. 49 Tenenbaum, F., Lumbroso, J., Schlumberger, M., Mure, A., Plouin, P.F., Caillou, B. & Parmentier, C. (1995) Comparison of radiolabeled octreotide and meta‐iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma. Journal of Nuclear Medicine, 36, 1–6.